Community Health Systems Inc. (CYH) reported $11.65B of revenue for the twelve months ended Sep 30, 2026. That is down 7.8% from the year before. Revenue for fiscal 2025 was $12.48B.

Yes. Community Health Systems Inc. earned $36.00M in net income for the twelve months ended Sep 30, 2026, a net margin of 0.3%.

How much cash and debt does CYH have?

Community Health Systems Inc. reported $155.00M in cash and cash equivalents and $9.57B of debt on its most recent balance sheet in SEC filings.

How fast is CYH revenue growing?

Community Health Systems Inc.'s revenue changed -1.2% in fiscal 2025, to $12.48B. Its compound annual growth rate was +1.2% over 5 years and -5.7% over 10 years.

What is CYH gross margin?

Community Health Systems Inc.'s gross profit was $9.96B on $11.65B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 85.5%.

What is CYH free cash flow?

Community Health Systems Inc. generated -$122.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $211.00M less capital expenditures.

What is CYH earnings per share?

Diluted earnings per share were $0.27 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CYH last report financial results?

The latest statements here come from Community Health Systems Inc.'s 10-Q filed on Oct 29, 2026, covering the period ended Sep 30, 2026.

Financials · CYH

Community Health Systems Inc. (CYH) financials

For the twelve months ended Sep 30, 2026, Community Health Systems Inc. reported $11.65B of revenue and $36.00M of net income.

Revenue, TTM: $11.65B
Revenue growth, YoY: -7.8%
Net income, TTM: $36.00M
Net income growth, YoY: -89.1%
Net margin: 0.3%
Free cash flow, TTM: -$122.00M
EPS, diluted, TTM: $0.27
EPS growth, YoY: -88.8%
Cash: $155.00M
Total debt: $9.57B
P/E: 8.85
P/S: 0.03
Market cap: $318.7M

Annual revenue$12.48B

FY2016FY2025

Annual net income$509.00M

FY2016FY2025

Annual free cash flow$208.00M

FY2016FY2025

CYH revenue and earnings growth

CYH revenueQ3 2026$2.76B

Quarter YoY: -10.7%
QoQ: -2.4%
FY YoY: -1.2%
5Y CAGR: +1.2%
10Y CAGR: -5.7%

CYH revenue was $2.76B in fiscal Q3 2026 (ended Sep 30, 2026), down 10.7% from a year earlier and down 2.4% from the prior quarter. For the full fiscal 2025 it was $12.48B, down 1.2% from fiscal 2024. Compound annual growth was +1.2% over 5 years and -5.7% over 10 years. It rose in 3 of the last 10 fiscal years.

CYH net incomeQ3 2026-$86.00M

5Y CAGR: -0.1%
10Y CAGR: +12.4%

CYH net income was -$86.00M in fiscal Q3 2026 (ended Sep 30, 2026), compared with $130.00M a year earlier. For the full fiscal 2025 it was $509.00M, compared with -$516.00M in fiscal 2024. Compound annual growth was -0.1% over 5 years and +12.4% over 10 years.

CYH EPSQ3 2026-$0.63

5Y CAGR: -3.0%
10Y CAGR: +10.7%

CYH diluted EPS was -$0.63 in fiscal Q3 2026 (ended Sep 30, 2026), compared with $0.96 a year earlier. For the full fiscal 2025 it was $3.77, compared with -$3.90 in fiscal 2024. Compound annual growth was -3.0% over 5 years and +10.7% over 10 years.

CYH free cash flowQ3 2026$67.00M

Quarter YoY: 17x
QoQ: +458.3%
FY YoY: +73.3%
5Y CAGR: -34.6%

CYH free cash flow was $67.00M in fiscal Q3 2026 (ended Sep 30, 2026), up about 17-fold from a year earlier and up 458.3% from the prior quarter. For the full fiscal 2025 it was $208.00M, up 73.3% from fiscal 2024. Compound annual growth was -34.6% over 5 years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$12.48B	$12.63B	$12.49B	$12.21B	$12.37B	$11.79B	$13.21B	$14.15B	$15.35B	$18.44B
Cost of revenue	$1.86B	$1.95B	$1.99B	$1.98B	$2.04B	$1.96B	$2.15B	$2.35B	$2.67B	$3.01B
Gross profit	$10.62B	$10.69B	$10.50B	$10.24B	$10.33B	$9.83B	$11.06B	$11.80B	$12.68B	$15.43B
Operating income	$1.49B	$542.00M	$957.00M	$821.00M	$1.40B	$1.13B	$650.00M	$208.00M	-$1.88B	-$860.00M
Pre-tax income	$724.00M	-$283.00M	$207.00M	$349.00M	$499.00M	$422.00M	-$430.00M	-$715.00M	-$2.83B	-$1.72B
Income tax	$48.00M	$79.00M	$191.00M	$170.00M	$131.00M	-$185.00M	$160.00M	-$11.00M	-$449.00M	-$104.00M
Net income	$509.00M	-$516.00M	-$133.00M	$46.00M	$230.00M	$511.00M	-$675.00M	-$788.00M	-$2.46B	-$1.72B
EPS, basic	$3.81	-$3.90	-$1.02	$0.35	$1.82	$4.43	-$5.93	-$6.99	-$22.00	-$15.54
EPS, diluted	$3.77	-$3.90	-$1.02	$0.35	$1.76	$4.39	-$5.93	-$6.99	-$22.00	-$15.54
Diluted shares	135.0M	132.1M	130.4M	130.1M	130.6M	116.5M	113.7M	112.7M	111.8M	110.7M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$260.00M	$37.00M	$38.00M	$118.00M	$507.00M	$1.68B	$216.00M	$196.00M	$563.00M	$238.00M
Receivables	$2.08B	$2.29B	$2.23B	$2.04B	$2.06B	$1.93B	$2.26B	$2.35B	$2.38B	$3.18B
Current assets	$3.23B	$3.30B	$3.21B	$3.08B	$3.48B	$4.51B	$3.43B	$3.55B	$4.07B	$4.67B
Goodwill	$3.32B	$3.79B	$3.96B	$4.17B	$4.22B	$4.22B	$4.33B	$4.56B	$4.72B	$6.52B
Total assets	$13.20B	$14.05B	$14.46B	$14.67B	$15.22B	$16.01B	$15.61B	$15.86B	$17.45B	$21.94B
Current liabilities	$2.21B	$2.35B	$2.14B	$2.19B	$2.36B	$2.81B	$2.28B	$2.39B	$2.36B	$2.89B
Short-term debt	-	-	-	-	-	-	-	$204.00M	-	-
Long-term debt	$10.38B	$11.43B	$11.47B	$11.61B	$12.11B	$12.09B	$13.38B	$13.39B	$13.88B	$14.79B
Total debt	$10.38B	$11.43B	$11.47B	$11.61B	$12.11B	$12.09B	$13.38B	$13.60B	$13.88B	$14.79B
Total liabilities	$14.04B	$15.37B	$15.28B	$15.40B	$16.03B	$17.06B	$17.25B	$16.82B	$17.61B	$19.66B
Shareholders' equity	-$1.39B	-$1.68B	-$1.15B	-$1.27B	-$1.29B	-$1.54B	-$2.14B	-$1.46B	-$692.00M	$1.73B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$543.00M	$480.00M	$210.00M	$300.00M	-$131.00M	$2.18B	$385.00M	$274.00M	$773.00M	$1.14B
Capital expenditures	$335.00M	$360.00M	$467.00M	$415.00M	$469.00M	$440.00M	$438.00M	$527.00M	$564.00M	$744.00M
Free cash flow	$208.00M	$120.00M	-$257.00M	-$115.00M	-$600.00M	$1.74B	-$53.00M	-$253.00M	$209.00M	$393.00M
Investing cash flow	$847.00M	-$275.00M	-$26.00M	-$259.00M	-$524.00M	$177.00M	-$2.00M	-$245.00M	$1.07B	$630.00M
Financing cash flow	-$1.17B	-$206.00M	-$264.00M	-$430.00M	-$514.00M	-$895.00M	-$363.00M	-$396.00M	-$1.52B	-$1.71B
Stock-based compensation	$11.00M	$17.00M	$22.00M	$20.00M	$25.00M	$13.00M	$10.00M	$13.00M	$24.00M	$46.00M
Depreciation and amortization	$426.00M	$486.00M	$505.00M	$534.00M	$540.00M	$558.00M	$608.00M	$700.00M	$861.00M	$1.10B

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	-1.2%	1.2%	2.3%	-1.3%	4.9%	-10.8%	-6.7%	-7.8%	-16.7%	-18.3%
Net income growth, YoY	-	-	-	-80.0%	-55.0%	-	-	-	-	-
EPS growth, YoY	-	-	-	-80.1%	-59.9%	-	-	-	-	-
Gross margin	85.1%	84.6%	84.0%	83.8%	83.5%	83.3%	83.7%	83.4%	82.6%	83.7%
Operating margin	11.9%	4.3%	7.7%	6.7%	11.3%	9.6%	4.9%	1.5%	-12.2%	-4.7%
Net margin	4.1%	-4.1%	-1.1%	0.4%	1.9%	4.3%	-5.1%	-5.6%	-16.0%	-9.3%
Free cash flow margin	1.7%	0.9%	-2.1%	-0.9%	-4.9%	14.7%	-0.4%	-1.8%	1.4%	2.1%
Return on equity	-	-	-	-	-	-	-	-	-	-99.6%
Return on assets	3.9%	-3.7%	-0.9%	0.3%	1.5%	3.2%	-4.3%	-5.0%	-14.1%	-7.8%
Current ratio	1.46	1.41	1.50	1.41	1.47	1.60	1.50	1.48	1.73	1.62
Debt to equity	-	-	-	-	-	-	-	-	-	8.56

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$2.76B	$2.83B	$2.96B	$3.11B	$3.09B	$3.13B	$3.16B	$3.27B	$3.09B	$3.14B	$3.14B	$3.18B
Cost of revenue	$407.00M	$401.00M	$441.00M	$446.00M	$460.00M	$469.00M	$489.00M	$507.00M	$469.00M	$483.00M	$487.00M	$494.00M
Gross profit	$2.35B	$2.42B	$2.52B	$2.66B	$2.63B	$2.66B	$2.67B	$2.76B	$2.62B	$2.66B	$2.65B	$2.69B
Operating income	$146.00M	$389.00M	$281.00M	$450.00M	$243.00M	$512.00M	$284.00M	$278.00M	-$205.00M	$238.00M	$231.00M	$327.00M
Pre-tax income	-$53.00M	$180.00M	$64.00M	$221.00M	-$2.00M	$438.00M	$67.00M	$64.00M	-$419.00M	$50.00M	$22.00M	$193.00M
Income tax	-$3.00M	$76.00M	$89.00M	$61.00M	-$173.00M	$118.00M	$42.00M	$92.00M	-$64.00M	$24.00M	$28.00M	$107.00M
Net income	-$86.00M	$70.00M	-$58.00M	$110.00M	$130.00M	$282.00M	-$13.00M	-$70.00M	-$391.00M	-$13.00M	-$41.00M	$47.00M
EPS, basic	-$0.63	$0.51	-$0.43	$0.83	$0.97	$2.11	-$0.10	-$0.53	-$2.95	-$0.10	-$0.32	$0.36
EPS, diluted	-$0.63	$0.51	-$0.43	$0.82	$0.96	$2.09	-$0.10	-$0.53	-$2.95	-$0.10	-$0.32	$0.36
Diluted shares	135.5M	136.5M	134.4M	-	135.2M	134.9M	132.9M	-	132.4M	132.3M	131.3M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$155.00M	$149.00M	$712.00M	$260.00M	$123.00M	$456.00M	$431.00M	$37.00M	$33.00M	$39.00M	$48.00M	$38.00M
Receivables	$2.10B	$2.14B	$2.14B	$2.08B	$2.16B	$2.26B	$2.33B	$2.29B	$2.04B	$2.19B	$2.19B	$2.23B
Current assets	$3.00B	$3.08B	$3.77B	$3.23B	$3.20B	$3.66B	$3.41B	$3.30B	$3.11B	$3.20B	$3.17B	$3.21B
Goodwill	$3.23B	$3.23B	$3.13B	$3.32B	$3.54B	$3.60B	$3.79B	$3.79B	$3.94B	$3.97B	$3.96B	$3.96B
Total assets	$12.11B	$12.18B	$13.18B	$13.20B	$13.24B	$13.64B	$13.89B	$14.05B	$13.90B	$14.41B	$14.42B	$14.46B
Current liabilities	$2.02B	$2.02B	$2.57B	$2.21B	$2.18B	$2.29B	$2.37B	$2.35B	$2.13B	$2.17B	$2.14B	$2.14B
Long-term debt	$9.57B	$9.55B	$10.13B	$10.38B	$10.59B	$10.84B	$11.30B	$11.43B	$11.47B	$11.50B	$11.53B	$11.47B
Total debt	$9.57B	$9.55B	$10.13B	$10.38B	$10.59B	$10.84B	$11.30B	$11.43B	$11.47B	$11.50B	$11.53B	$11.47B
Total liabilities	$13.04B	$13.02B	$14.14B	$14.04B	$14.19B	$14.74B	$15.22B	$15.37B	$15.18B	$15.29B	$15.29B	$15.28B
Shareholders' equity	-$1.49B	-$1.16B	-$1.23B	-$1.39B	-$1.27B	-$1.41B	-$1.69B	-$1.68B	-$1.59B	-$1.20B	-$1.21B	-$1.15B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$154.00M	$88.00M	-$297.00M	$266.00M	$69.00M	$88.00M	$120.00M	$216.00M	$67.00M	$101.00M	$96.00M	$90.00M
Capital expenditures	$87.00M	$76.00M	$76.00M	$94.00M	$65.00M	$91.00M	$85.00M	$109.00M	$70.00M	$88.00M	$93.00M	$110.00M
Free cash flow	$67.00M	$12.00M	-$373.00M	$172.00M	$4.00M	-$3.00M	$35.00M	$107.00M	-$3.00M	$13.00M	$3.00M	-$20.00M
Investing cash flow	-$106.00M	-$23.00M	$1.02B	$142.00M	-$81.00M	$342.00M	$444.00M	-$143.00M	$75.00M	-$108.00M	-$99.00M	$180.00M
Financing cash flow	-$42.00M	-$628.00M	-$274.00M	-$271.00M	-$321.00M	-$405.00M	-$170.00M	-$69.00M	-$148.00M	-$2.00M	$13.00M	-$323.00M
Stock-based compensation	$3.00M	$2.00M	$3.00M	$4.00M	-$1.00M	$3.00M	$4.00M	$5.00M	$4.00M	$2.00M	$6.00M	$6.00M
Depreciation and amortization	$106.00M	$108.00M	$114.00M	$109.00M	$108.00M	$105.00M	$105.00M	$129.00M	$117.00M	$125.00M	$115.00M	$121.00M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	-10.7%	-9.8%	-6.1%	-4.9%	-0.1%	-0.2%	0.6%	2.6%	0.1%	0.8%	1.0%	1.3%
Net income growth, YoY	-	-75.2%	-	-	-	-	-	-	-	-	-	-88.7%
EPS growth, YoY	-	-75.6%	-	-	-	-	-	-	-	-	-	-88.8%
Gross margin	85.2%	85.8%	85.1%	85.6%	85.1%	85.0%	84.5%	84.5%	84.8%	84.6%	84.5%	84.5%
Operating margin	5.3%	13.8%	9.5%	14.5%	7.9%	16.3%	9.0%	8.5%	-6.6%	7.6%	7.4%	10.3%
Net margin	-3.1%	2.5%	-2.0%	3.5%	4.2%	9.0%	-0.4%	-2.1%	-12.7%	-0.4%	-1.3%	1.5%
Free cash flow margin	2.4%	0.4%	-12.6%	5.5%	0.1%	-0.1%	1.1%	3.3%	-0.1%	0.4%	0.1%	-0.6%
Current ratio	1.48	1.53	1.47	1.46	1.47	1.59	1.44	1.41	1.46	1.47	1.49	1.50

Source: XBRL data Community Health Systems Inc. files with the SEC, latest filing dated Oct 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CYH peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CYH	$11.65B	-7.8%	$36.00M	0.3%	$318.7M
HCAHCA Healthcare Inc.	$78.70B	+5.8%	$6.78B	8.6%	$105.47B
THCTenet Healthcare Corporation	$22.15B	+6.2%	$2.90B	13.1%	$23.00B
EHCEncompass Health Corporation	$6.34B	+9.4%	$644.40M	10.2%	$13.85B
UHSUniversal Health Services Inc.	$18.35B	+8.0%	$1.46B	8.0%	$11.62B
ENSGThe Ensign Group Inc.	$5.67B	+17.5%	$399.12M	7.0%	$10.62B
PACSPACS Group Inc.	$5.71B	+11.0%	$277.58M	4.9%	$7.74B
SGRYSurgery Partners Inc.	$3.36B	+2.2%	-$87.00M	-2.6%	$3.46B
NHCNational HealthCare Corporation	$1.58B	+5.6%	$115.13M	7.3%	$3.29B

CYH FAQ

9 questions

What is CYH revenue?
Community Health Systems Inc. (CYH) reported $11.65B of revenue for the twelve months ended Sep 30, 2026. That is down 7.8% from the year before. Revenue for fiscal 2025 was $12.48B.
Is CYH profitable?
Yes. Community Health Systems Inc. earned $36.00M in net income for the twelve months ended Sep 30, 2026, a net margin of 0.3%.
How much cash and debt does CYH have?
Community Health Systems Inc. reported $155.00M in cash and cash equivalents and $9.57B of debt on its most recent balance sheet in SEC filings.
How fast is CYH revenue growing?
Community Health Systems Inc.'s revenue changed -1.2% in fiscal 2025, to $12.48B. Its compound annual growth rate was +1.2% over 5 years and -5.7% over 10 years.
What is CYH gross margin?
Community Health Systems Inc.'s gross profit was $9.96B on $11.65B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 85.5%.
What is CYH free cash flow?
Community Health Systems Inc. generated -$122.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $211.00M less capital expenditures.
What is CYH earnings per share?
Diluted earnings per share were $0.27 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CYH last report financial results?
The latest statements here come from Community Health Systems Inc.'s 10-Q filed on Oct 29, 2026, covering the period ended Sep 30, 2026.
Where does this CYH financial data come from?
Quantisnow builds these statements from the structured XBRL data Community Health Systems Inc. files with the SEC. It is provided for information only and is not investment advice.